Lecture preview | Establishment and application of intestinal dominant bacteria detection method

Release time:2025/9/8

Lecture time

September 11, 2025 16:00-19:00


Lecture location

Conference Room 3-117, Building 3, Jinfeng Laboratory


Lecture topic: Establishment and application of intestinal dominant bacteria detection method


Introduction to the speaker

1.png


Li Bo , Assistant Researcher of the National Key Laboratory of Infectious Disease Diagnosis and Treatment of Infectious Diseases, Harvard Medical School/Massachusetts General Hospital was engaged in the research and application of micro-nano processing from 2012 to 2015. From 2016 to the present, under the guidance of Academician Li Lanjuan of the National Key Laboratory of Infectious Disease Diagnosis and Treatment of Infectious Diseases, Zhejiang University First Hospital, has carried out the application of microecological diagnosis and treatment technology in the field of infectious diseases. In recent years, it has undertaken projects such as "Research on the Mechanism and Countermeasures of Microecology Influencing the Health of the Human Age" and "Research on the Effects of Intestinal Fungi on the Prognosis of People with Abnormal Sugar Metabolism" in the National Key R&D Plan. It is mainly responsible for the development of intestinal microecology detection, ten-joint detection reagents and equipment for intestinal advantageous fungi, and targeted screening of probiotics.


Lecture introduction


The human intestine is an extremely complex microecosystem, and the bacterial flora are closely related to human health. They not only participate in digestion, but also play a key role in human development, immune regulation and other processes. Once the intestinal microecology is unbalanced, the risk of infection, inflammatory diseases and other diseases will increase significantly. However, effective methods for evaluating the gut microbiome using a small number of fecal microorganisms have been previously lacking. Li Bo’s team screened out a variety of dominant bacteria that can characterize the entire intestinal flora from a cohort of large sample population in China, and constructed a set of efficient, operational and well-quantitative detection methods. This research result provides a new way for clinical timely detection of intestinal microbial disorders and achieve early diagnosis and treatment. In the future, the team will consider the impact of region on intestinal flora, collect samples from different regions and re-establish classification models, further improve relevant theories and applications, and continue to help the cause of human health.


Everyone is welcome to actively participate